PDS Biotechnology Corporation (FRA:EU6)
Germany
· Delayed Price · Currency is EUR 0.723
+0.076 (11.66%)
Last updated: Dec 4, 2025, 8:07 AM CET
PDS Biotechnology Statistics
Total Valuation
FRA:EU6 has a market cap or net worth of EUR 40.92 million. The enterprise value is 33.85 million.
| Market Cap | 40.92M |
| Enterprise Value | 33.85M |
Important Dates
The next estimated earnings date is Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 54.72M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +22.47% |
| Shares Change (QoQ) | +2.11% |
| Owned by Insiders (%) | 2.58% |
| Owned by Institutions (%) | 10.16% |
| Float | 53.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 5.08 |
| P/TBV Ratio | 5.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.14 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 1.90.
| Current Ratio | 2.09 |
| Quick Ratio | 1.97 |
| Debt / Equity | 1.90 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.06 |
Financial Efficiency
Return on equity (ROE) is -221.81% and return on invested capital (ROIC) is -54.38%.
| Return on Equity (ROE) | -221.81% |
| Return on Assets (ROA) | -46.22% |
| Return on Invested Capital (ROIC) | -54.38% |
| Return on Capital Employed (ROCE) | -150.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.24M |
| Employee Count | 24 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -997,038 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.47% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -65.47% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 1.03 |
| Relative Strength Index (RSI) | 54.44 |
| Average Volume (20 Days) | 2,909 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -27.47M |
| Pretax Income | -30.73M |
| Net Income | -29.73M |
| EBITDA | -27.42M |
| EBIT | -27.47M |
| Earnings Per Share (EPS) | -0.69 |
Balance Sheet
The company has 22.33 million in cash and 15.31 million in debt, giving a net cash position of 7.02 million.
| Cash & Cash Equivalents | 22.33M |
| Total Debt | 15.31M |
| Net Cash | 7.02M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 8.06M |
| Book Value Per Share | 0.17 |
| Working Capital | 12.41M |
Cash Flow
| Operating Cash Flow | -27.52M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:EU6 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.47% |
| Shareholder Yield | -22.47% |
| Earnings Yield | -72.65% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 18, 2019. It was a reverse split with a ratio of 0.05.
| Last Split Date | Mar 18, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |